Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine July 2016, 57 (7) 8A;
  • Article
  • Info & Metrics
  • PDF
Loading

MR/PET in neurology: Heiss looks at the development of simultaneous PET and MR clinical data acquisition and at current activities and future potential for synergetic real-time recording of functional, metabolic, physiologic, and morphologic data.

Page 993

Immuno-PET of EGFRs: Kramer-Marek and Oyen describe the status of human epidermal growth factor receptor–specific imaging agents and efforts to move these molecular probes from early preclinical studies to clinical trials.

Page 996

177Lu-PSMA in prostate cancer: Kwekkeboom offers perspective on the use of 177Lu-labeled prostate-specific membrane antigen ligands in therapy targeting castration-resistant prostate cancer cells and previews a related article in this issue of JNM.

Page 1002

Chemokine receptor imaging: Bengel provides insight into research targeting visualization and quantification of the chemokine–chemokine receptor axis, with a focus on potential roles in exploring inflammatory processes.

Page 1004

177Lu-PSMA assessment: Baum and colleagues report on the safety and efficacy of a 177Lu-labeled DOTAGA-based prostate-specific membrane antigen ligand in patients with metastatic castration-resistant prostate cancer.

Page 1006

Dose–response in 90Y radioembolization: van den Hoven and colleagues characterize the relationship between tumor-absorbed dose and response after 90Y-microsphere radioembolization in patients with colorectal liver metastases.

Page 1014

Sphere numbers in radioembolization: Pasciak and colleagues investigate microscopic absorbed-dose heterogeneity in 90Y radioembolization as a function of microsphere numbers per unit volume in tumors and discuss potential related effects on tumor control and treatment planning.

Page 1020

Dose–response in DTC with 124I: Wierts and colleagues use a fixed-activity approach in 124I PET/CT quantification of the dose–response relationship in 124I-sodium iodide treatment of differentiated thyroid cancer.

Page 1027

NSCLC tumor heterogeneity: Tixier and colleagues quantify differences between volumetry, uptake, and heterogeneity features extracted from static and parametric PET images of non–small cell lung carcinoma and describe the potential added value of parametric images.

Page 1033

18F-FDG uptake and HER2 expression: Chen and colleagues investigate an association between human epidermal growth factor receptor 2 expression and tracer uptake and the potential for 18F-FDG PET/CT prediction of HER2 status in gastric cancer.

Page 1040

Posttransplantation volumetric PET in HCC: Kim and colleagues compare recently introduced metabolic and volumetric 18F-FDG PET/CT indices with current clinicopathologic data as predictors of hepatocellular carcinoma recurrence after liver transplantation.

Page 1045

PET/CT and liver metastasis ablation: Cornelis and colleagues determine whether 18F-FDG PET/CT and contrast-enhanced CT performed immediately after percutaneous ablation of liver metastases are predictors of local treatment failure at 1 year.

Page 1052

18F-choline PET/CT in CRPC: Lee and colleagues explore the serial application of metabolically active tumor volume measurements from 18F-fluorocholine PET/CT as systemic treatment response markers and predictors of disease progression in patients with castration-resistant prostate cancer.

Page 1058

18F-choline PET/MR for prostate biopsy: Piert and colleagues compare the value of fusion 18F-fluoromethylcholine PET/MR imaging for targeted prostate biopsies with that of standard systematic 12-core biopsies to detect significant prostate cancer.

Page 1065

11C-DED and 11C-PiB in brain perfusion: Rodriguez-Vieitez and colleagues compare early-phase 11C-DED and 11C-Pittsburgh compound B PET imaging as surrogate markers of brain perfusion in cognitive decline and determine the extent to which brain perfusion influences 11C-DED binding.

Page 1071

Variable-depth 3D-SSP for amyloid PET: Lilja and colleagues report on a method for 3-dimensional stereotactic surface projection quantification and visualization of 18F-flutemetamol images that avoids extraction of white matter signal.

Page 1078

Motion correction for dynamic PET: Yu and colleagues apply an event-by-event respiratory motion–correction method, correlating internal organ motion and external respiratory signals, to human dynamic PET studies and investigate the impact on kinetic parameter estimation.

Page 1084

ASiR and bone SPECT/CT: Sibille and colleagues compare a routine bone SPECT/CT protocol using CT reconstructed with filtered backprojection with an optimized protocol using low-dose CT images reconstructed with adaptive statistical iterative reconstruction.

Page 1091

MR-AC reproducibility and LBM extraction: Rausch and colleagues assess the reproducibility of standard Dixon-based attenuation correction in PET/MR imaging and use resulting data to estimate patient-specific lean body mass.

Page 1096

Lesion number, PERCIST, and breast cancer: Pinker and colleagues explore the question of whether and how the number of analyzed lesions affects standardized response assessment in metastatic breast cancer.

Page 1102

Immuno-PET and RIT in ESCC: Song and colleagues study the abilities of 64Cu-cetuximab immuno-PET to image epidermal growth factor receptor expression levels in esophageal squamous cell carcinoma tumors and of 177Lu-cetuximab radioimmunotherapy to inhibit tumor growth in mouse models.

Page 1105

Tissue factor imaging in pancreatic cancer: Nielsen and colleagues investigate the possibility of using active site–inhibited factor VII labeled with 64Cu for PET imaging of tissue factor expression in mice with pancreatic adenocarcinomas.

Page 1112

Biodistribution of NTR1 antagonists: Schulz and colleagues evaluate the biodistribution profiles of a series of newly developed diarylpyrazole-based neurotensin receptor–1 antagonists for suitability as diagnostic and radiotherapeutic agents.

Page 1120

Nanoparticle imaging of atherosclerosis: Luehmann and colleagues describe a targeted nanoparticle for sensitive and specific detection of chemokine receptors regulating trafficking of inflammatory cells in a mouse vascular injury model and in a mouse atherosclerosis model.

Page 1124

High-resolution mouse brain PET scanner: Yang and colleagues detail the development of a prototype small-animal PET scanner based on depth-encoding detectors using dual-ended readout of small scintillator elements to produce high and uniform spatial resolution.

Page 1130

Single-cell 18F-FLT characterization: Sengupta and Pratx use a novel in vitro radioluminescence microscopy technique to measure the differential distribution of 18F-FLT radiotracer with single-cell precision.

Page 1136

PET mapping for brain–computer interface: Zhu and colleagues investigate the use of PET mapping for brain–computer interface stimulation in a rat model with electrodes implanted in the ventroposterior medial thalamus.

Page 1141

Nuclear medicine physics training: Harkness and Fahey summarize the findings of an American Association of Physicists in Medicine/SNMMI joint task force reviewing nuclear medicine physics training and identifying ways to improve future training opportunities.

Page 1146

Administered activities in pediatrics: Fahey and colleagues present part 2 of the final report of the Nuclear Medicine Global Initiative, surveying standards and practice for administered activities in children and offering recommendations toward global standardization of radiopharmaceutical administration.

Page 1148

  • © 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (7)
Journal of Nuclear Medicine
Vol. 57, Issue 7
July 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Jul 2016, 57 (7) 8A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Jul 2016, 57 (7) 8A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Dose–Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
  • Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non–Small Cell Lung Cancer
  • Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT
  • Targeting the Human Epidermal Growth Factor Receptors with Immuno-PET: Imaging Biomarkers from Bench to Bedside
  • A Prototype High-Resolution Small-Animal PET Scanner Dedicated to Mouse Brain Imaging
  • Event-by-Event Continuous Respiratory Motion Correction for Dynamic PET Imaging
  • Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
  • 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies
  • PET Mapping for Brain–Computer Interface Stimulation of the Ventroposterior Medial Nucleus of the Thalamus in Rats with Implanted Electrodes
  • Comparative Evaluation of the Biodistribution Profiles of a Series of Nonpeptidic Neurotensin Receptor-1 Antagonists Reveals a Promising Candidate for Theranostic Applications
  • The Role of Attractiveness: Imaging the Interaction Between Cardiovascular and Immune System
  • PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site–Inhibited Factor VII
  • Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT
  • Reproducibility of MRI Dixon-Based Attenuation Correction in Combined PET/MR with Applications for Lean Body Mass Estimation
  • Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy
  • Standardization of Administered Activities in Pediatric Nuclear Medicine: A Report of the First Nuclear Medicine Global Initiative Project, Part 2—Current Standards and the Path Toward Global Standardization
  • The Current State of Nuclear Medicine Physics Training: Findings of the AAPM/SNMMI Task Force
  • Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer
  • A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization
  • 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation
  • 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
  • PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles
  • Impact of the Adaptive Statistical Iterative Reconstruction Technique on Radiation Dose and Image Quality in Bone SPECT/CT
  • Insights into the Dose–Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases
  • Hybrid PET/MR Imaging in Neurology: Present Applications and Prospects for the Future
  • Perspective on 177Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
  • Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease
  • Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth
  • The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire